Chen‐Hong Ding
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Hepatology top 10%
Papers in
-
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Ubiquitin and proteasome pathways 2
-
- Liver physiology and pathology 4
- Co-authors
- Wei‐Fen Xie (18 shared papers)Xin Zhang (8 shared papers)Jin Ding (4 shared papers)Cheng Luo (5 shared papers)Jinpei Liu (3 shared papers)Shijie Chen (5 shared papers)Wenping Xu (4 shared papers)Kai Ding (4 shared papers)
- Journals
- Journal of Hepatology (2 papers)Cancer Research (2 papers)Cell Death and Disease (2 papers)Nature Communications (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chen‐Hong Ding
19 papers receiving 555 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 205
- Hepatology 44
- Molecular Biology 350
- Epidemiology 86
- Immunology 54
Countries citing papers authored by Chen‐Hong Ding
This map shows the geographic impact of Chen‐Hong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Hong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Hong Ding more than expected).
Fields of papers citing papers by Chen‐Hong Ding
This network shows the impact of papers produced by Chen‐Hong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Hong Ding. The network helps show where Chen‐Hong Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen‐Hong Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 112 | |
| 2 | 2019 | 90 | |
| 3 | 2018 | 69 | |
| 4 | 2015 | 64 | |
| 5 | 2018 | 61 | |
| 6 | 2019 | 40 | |
| 7 | 2024 | 30 | |
| 8 | 2025 | 17 | |
| 9 | 2013 | 16 | |
| 10 | 2022 | 12 | |
| 11 | 2024 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2017 | 8 | |
| 14 | 2025 | 6 | |
| 15 | 2021 | 6 | |
| 16 | 2025 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Chen‐Hong Ding
Chen‐Hong Ding is a scholar working on Molecular Biology, Hepatology, Immunology, Epidemiology and Cell Biology, having authored 23 papers that have together received 558 indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Ubiquitin and proteasome pathways (2 papers), Galectins and Cancer Biology (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Cancer Research (205 citations), Hepatology (44 citations), Molecular Biology (350 citations), Epidemiology (86 citations) and Immunology (54 citations). Chen‐Hong Ding has collaborated with scholars based in China and United States. Frequent co-authors include Wei‐Fen Xie, Xin Zhang, Jin Ding, Cheng Luo, Jinpei Liu, Shijie Chen, Wenping Xu, Kai Ding, Shuqing Liu and Liangzhi Wen. Their work appears in journals such as Journal of Hepatology, Cancer Research, Cell Death and Disease, Nature Communications and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.